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The state of asthma epidemiology: an 
overview of systematic reviews and their quality
Jon Genuneit1* , Annina M. Seibold1, Christian J. Apfelbacher2, George N. Konstantinou3, Jennifer J. Koplin4, 
Stefania La Grutta5, Kirsty Logan6, Carsten Flohr7, Michael R. Perkin8 and for the Task Force “Overview of 
Systematic Reviews in Allergy Epidemiology (OSRAE)” of the EAACI Interest Group on Epidemiology
Abstract 
Background: Recently, we have published an overview of systematic reviews in allergy epidemiology and identified 
asthma as the most commonly reviewed allergic disease. Building on this work, we aimed to investigate the quality of 
systematic reviews in asthma using the AMSTAR checklist and to provide a reference for future, more in-depth assess-
ment of the extent of previous knowledge.
Methods: We included all 307 systematic reviews indexed with asthma, including occupational asthma, and/or 
wheeze from our previous search in PubMed and EMBASE up to December 2014 for systematic reviews on epide-
miological research on allergic diseases. Topics of the included systematic reviews were indexed and we applied the 
AMSTAR checklist for methodological quality to all. Statistical analyses include description of lower and upper bounds 
of AMSTAR scores and variation across publication time and topics.
Results: Of 43 topics catalogued, family history, birth weight, and feeding of formula were only covered once in 
systematic reviews published from 2011 onwards. Overall, at least one meta-analysis was conducted for all top-
ics except for “social determinants”, “perinatal”, “birth weight”, and “climate”. AMSTAR quality scores were significantly 
higher in more recently published systematic reviews, in those with meta-analysis, and in Cochrane reviews. There 
was evidence of variation of quality across topics even, after accounting for these characteristics. Genetic factors in 
asthma development were often covered by systematic reviews with some evidence of unsubstantiated updates or 
repetition.
Conclusions: We present a comprehensive overview with an indexed database of published systematic reviews in 
asthma epidemiology including quality scores. We highlight some topics including active smoking and pets, which 
should be considered for future systematic reviews. We propose that our search strategy and database could be a 
basis for topic-specific overviews of systematic reviews in asthma epidemiology.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The state of current knowledge of asthma epidemiol-
ogy has been summarised in numerous narrative expert 
reviews including the Global Atlas of Asthma of the 
European Academy of Allergy and Clinical Immunology 
and the European Lung White Book of the European Res-
piratory Society [1, 2]. With an ever increasing number of 
systematic reviews on asthma epidemiology, systematic 
overviews of these systematic reviews become more and 
more important to keep track of the evidence, to prevent 
redundancy, and to provide comprehensive summaries 
informing decision makers. However, to date there are 
only two overviews of systematic reviews in asthma epi-
demiology and both only cover specific aspects of asthma 
epidemiology [3, 4].
One overview of systematic reviews, providing a meta-
analysis of risk and protective factors on childhood 
asthma, included 42 systematic reviews published up to 
January 2016 [3]. Of note, this was focused on childhood, 
on non-genetic factors, and on systematic reviews with 
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meta-analysis. Another overview of systematic reviews 
was restricted to the association of diet with asthma [4]. 
We are also aware of three systematic reviews which have 
examined the original literature rather than systematic 
reviews on some areas of asthma epidemiology: The first 
searched for articles describing risk factors for asthma 
incidence and the second aimed at comprehensively 
reviewing the original literature on selected risk and pro-
tective factors for asthma [5, 6]. The third conducted a 
more specific search to identify original articles on the 
genetic predisposition to asthma and atopy over a period 
of 6 years [7].
Recently, we have published a comprehensive over-
view on systematic reviews in allergy epidemiology which 
has identified a total of 307 systematic reviews covering 
asthma and wheeze [8]. Building on our previous work, 
we aimed here to investigate the systematic reviews’ 
quality using the AMSTAR checklist [9] and to provide a 
reference for future, more in-depth assessments of indi-
vidual topic areas.
Methods
The complete search strategy has been published previ-
ously [8]. In brief, we searched PubMed and EMBASE 
(via OVID, including conference abstracts) for systematic 
reviews on epidemiological research on allergic diseases. 
The databases were searched from their inception with-
out restrictions, in particular with regard to language, 
publication period, or data on humans; the last update of 
the search was carried out on December 17, 2014.
Following removal of duplicates, titles and abstracts 
were screened for potential relevance and in that case 
full-text was obtained. Exclusion criteria were: (1) clear 
indication of lack of a systematic search (e.g. narrative 
reviews or meta-analyses of data from multiple study 
centres), (2) no human data presented (e.g. animal data, 
in vitro studies, simulation studies), (3) outcome defini-
tion that did not include asthma or wheeze, and (4) the 
investigated topic was the management of existing dis-
ease (e.g. therapeutic intervention, patient education, 
secondary and tertiary prevention). References of over-
views of systematic reviews were scrutinised for sys-
tematic reviews and these were included if not already 
identified through the search strategy. All evaluation of 
entries and full texts was conducted by two members 
of the review team independently and the senior author 
settled cases of disagreement. The studied diseases and 
topics covered by the systematic reviews were indexed as 
previously described; here we analyse all 307 systematic 
reviews covering asthma, including occupational asthma, 
and/or wheeze [8].
Complete citations of the included reviews were 
extracted; we categorized the year of (print) publication 
into three periods: before 2006, 2006–2010, after 2010 
(bands chosen with consideration of the number of arti-
cles in each period at the time of analysis). The type of 
systematic review, i.e. systematic review, systematic 
review with meta-analysis, or overview of systematic 
reviews, and the studied topics covered were taken from 
the previously published index [8]. For the outcomes and 
the topics, we extracted the definitions presented in the 
systematic reviews and any age restrictions that were 
applied. Data extraction was conducted independently by 
two members of the review team. The lead author settled 
any cases of disagreement.
In addition, two members of the review team inde-
pendently applied the AMSTAR checklist to all relevant 
full-text entries [9, 10]. This is the most frequently used 
validated checklist to evaluate the methodological quality 
of systematic reviews. It has been previously noted that 
the wording of the AMSTAR items and instructions is a 
trade-off between feasibility and reliability [11]. Because 
of the subjective interpretation, inter-rater agreement 
on some AMSTAR items may be lower than on others. 
Rather than solving disagreement between raters and 
producing one averaged AMSTAR score, we deliberately 
instructed one rater to be more liberal and the other rater 
to be more conservative in applying the AMSTAR check-
list. Thus, we documented an upper bound (liberal) and 
a lower bound (conservative) of the total AMSTAR score 
that may be achieved by each systematic review. Details 
of the liberal and conservative criteria for each AMSTAR 
item are shown in Additional file 1: Table S1.
For two of the systematic reviews, the extracted data 
were based on the abstract and those parts of the full 
text that could be translated [12, 13]. Full application of 
the AMSTAR checklist was not possible due to the lim-
ited information included in the abstracts. Therefore, 
these two articles were excluded from the analyses of the 
AMSTAR scores.
All evaluation, data extraction, and indexing was per-
formed using a relational database (Microsoft Access 
2010©, Microsoft Corporation, Redmond, Washington, 
United States). Counts, percentages, and distributions 
as well as correlations and p values were analysed using 
SAS® 9.3 (The SAS Institute, Cary, NC, USA). To assess 
differences in the systematic reviews’ quality across top-
ics, we modelled linear regression with AMSTAR scores 
as the dependent variable and separate independent 
dummy variables per topic (each yes/no) since some sys-
tematic review were indexed with multiple topics. We 
report p values for the likelihood ratio test of the global 
association of topics with AMSTAR scores from these 
models and after further adjustment for other variables 
influencing the AMSTAR score. Also, we visualized the 
predicted mean AMSTAR scores per topic after centring 
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all topic dummy variables and all co-variables at their 
respective arithmetic mean. Data visualisation in Fig.  1 
was produced using Gephi© (https://gephi.org/), a non-
profit open-source software for network visualization 
and analysis created by the Gephi Consortium.
Results
Additional file 2: Appendix S2 contains the full list of the 
included 307 systematic reviews, including the indexed 
diseases and topics as well as the AMSTAR checklist in 
a single spreadsheet, which can be searched and sorted. 
Overall, 57.0% of the systematic reviews included a meta-
analysis. There were two overviews of systematic reviews, 
both not confined to asthma: one on second-hand smoke 
exposure and child health and the other on occupational 
safety and health interventions [14, 15].
Figure 1 depicts the aggregated topics (see Additional 
file  1: Table S2) indexed along with asthma or wheeze. 
If the line thickness matches the bubble diameter, this 
means that all articles indexed with that topic were 
indexed with asthma; if the line is thinner than the bubble 
diameter, the topic is also indexed solely with other aller-
gic diseases as previously published [8]. E.g. for “obesity”, 
almost all systematic reviews displayed data on asthma, 
whereas for “pre-/probiotics”, most systematic reviews 
covered only other allergic diseases. Of the full list of 43 
topics catalogued (see Additional file 1: Table S2), “fam-
ily history”, “birth weight”, and feeding of “formula” were 
only covered once in systematic reviews published from 
2011 onwards. The other topics were covered at least 
twice. Overall, at least one meta-analysis was conducted 
for all topics except for “social determinants”, “perinatal”, 
“birth weight”, and “climate”.
Overall, following the liberal and the conserva-
tive instructions, 63.0 and 13.1% respectively, had 
an AMSTAR score ≥8 which suggests good meth-
odological quality. The AMSTAR score increased 
over the time period studied (Fig.  2; liberal AMSTAR: 
asthma
therapeutic
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incidence
time trend
age
rural/urban
social determinants
race/ethnicity
migration
gene-environment
interaction
genetic
family history
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sex hormones
comorbidity
allergic comorbidity
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delivery mode
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agematernal
obesitybirth
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physical
activity
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formula
fatty acids
vitamins
antioxidants
diet
medication
pre-/probiotics
microbes
dampness
infections
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smoking
chemicals
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pollution climate
Fig. 1 Aggregated topics indexed along with asthma. The figure is based on the aggregated indexed topics which are presented in the same 
clockwise order as listed in Additional file 1: Table S2. Bubble diameter is proportional to the number of systematic reviews with the respective 
index term (this number is based on all n = 421 systematic reviews on allergy epidemiology, also non-asthma systematic reviews (based on the 
aggregated disease index term “asthma”), included in our previous overview [8]). Line thickness is proportional to the number of systematic reviews 
indexed with the connected index terms. Colours are arbitrary, covering the spectrum from blue to red in clockwise order
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pKruskal–Wallis,2DF < 0.001, Spearman ρ = 0.34; conservative 
AMSTAR: pKruskal–Wallis,2DF < 0.001, Spearman ρ = 0.21). 
This trend happened against the background of an 
increasing number of systematic reviews per year over 
time (Fig. 2). Also, the proportion of systematic reviews 
with meta-analysis increased over time up to 65.5% in the 
most recent period from 2011 to 2014 (p
χ2
< 0.001). In 
the same years, 76.3 and 11.8% had high (AMSTAR ≥8) 
and 5.3 and 27.2% had low (AMSTAR <4) methodological 
quality following the liberal and the conservative instruc-
tions, respectively. Systematic reviews with meta-analysis 
had a 3.0- and 2.0-points higher liberal and conservative 
AMSTAR score, respectively, compared to systematic 
reviews without meta-analysis (data not shown).
The AMSTAR score also differed across aggregated 
topics (Fig.  3; Additional file  1: Figure S1; for infor-
mation on aggregation of topics see Additional file  1: 
Table S2). This difference was not explained by effects 
of publication period or methodology (Additional 
file  1: Figure S1). Further adjustment for Cochrane ver-
sus non-Cochrane reviews resulted in decreasing aver-
age AMSTAR scores for topics with Cochrane reviews 
(2 for “allergens”, 7 for “diet”, 4 for “microbes”; data not 
shown). The global test for association of topics with 
AMSTAR scores in these fully adjusted models was pLR-
test =  0.063 and pLR-test =  0.040 for the liberal and con-
servative AMSTAR score, respectively. The proportion of 
variance in AMSTAR scores explained by topics, meas-
ured as r2 in the linear regression models, reduced from 
15.3 and 10.4% in the crude models to 3.9 and 5.1% in 
the fully adjusted models for the liberal and conserva-
tive AMSTAR score, respectively. Overall, 48.4 and 36.4% 
of the variance were explained in the fully adjusted 
models for the liberal and the conservative AMSTAR, 
respectively.
Of the full list of 43 topics (see Additional file 1: Table 
S2), only “birth weight” did not include a systematic 
review reaching a liberal AMSTAR of at least 8 which 
indicates good methodological quality. Restricting to 
more recent systematic reviews published after 2010, 
“pets” was another topic in which the systematic review 
published in this period achieved a liberal AMSTAR 
below 8 as well. Using the conservative AMSTAR, the 
list of topics with all systematic reviews achieving scores 
below 8 is much longer: “therapeutic”, “prevalence/inci-
dence”, “time trend”, “age”, “rural/urban”, “race/ethnicity”, 
“genetic”, “family history”, “sex”, “sex hormones”, “allergic 
comorbidity”, “perinatal”, “delivery mode”, “birth weight”, 
“obesity”, “physical activity”, “breastfeeding”, “dampness”, 
“pets”, “chemical”, “indoor air pollution”, “outdoor air pol-
lution”, and “climate”.
The topic covered most often was “genetic” (n  =  76) 
although this would have been outnumbered if all “envi-
ronmental” topics were aggregated. Table  1 shows the 
number of systematic reviews pertaining to the respective 
genes that were investigated. Of note, most of these sys-
tematic reviews only included case–control studies and 
family studies were typically excluded or not discussed. 
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Following mutual adjustment for the other topics, 87.8% 
of the systematic reviews on genetics had performed 
meta-analyses, a significantly higher proportion than for 
other topics. Several systematic reviews concentrated on 
single polymorphisms rather than all polymorphisms in a 
given gene or location.
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Fig. 3 Box plots of conservative (top, solid) and liberal (bottom, hatched) total AMSTAR scores over indexed topics. Topics are coloured from blue to 
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Four systematic reviews investigated gene-environ-
ment interactions: one on multiple genes and respiratory 
syncytial virus (RSV) infection [16], one on glutathione 
S-transferase genes and smoking [17], one on multiple 
genes and exposure to outdoor air pollution [18], and 
one on CD14 and exposure to microbes [19]. In addition, 
there were two systematic reviews with meta-analysis of 
genome-wide linkage studies [20, 21] and one system-
atic review with meta-analysis of studies on the effects of 
maternal and paternal asthma [22]. A further systematic 
review investigated the association between migration 
status and asthma with the aim of providing information 
on genetic and environmental components of the disease 
risk [23].
Discussion
We present a comprehensive overview of systematic 
reviews in asthma epidemiology including their meth-
odological quality which demonstrates that there are 
systematic reviews for most of the topics identified as rel-
evant in recent expert opinion pieces [1, 2]. Most topics 
have been covered by more than one systematic review 
and have also been covered since 2010. However, a sub-
stantial number of published systematic reviews fall short 
in methodological quality.
Compared to the only previous overview of systematic 
reviews across several topics in asthma epidemiology [3], 
we miss 9 systematic reviews identified by the other over-
view due to its 13 month longer search period up to Janu-
ary 2016. However, we also include 15 systematic reviews 
this overview failed to identify despite matching its inclu-
sion criteria. Because this other overview was restricted 
to systematic reviews with meta-analysis, on childhood, 
and on non-genetic factors [3], our more comprehen-
sive search identified 256 additional articles. Inevitably, 
such a comprehensive effort is outdated upon publica-
tion. Our previously published overview [8] suggests that 
about 70 systematic reviews on allergy epidemiology are 
published per year from 2014 on, of which about 75% are 
on asthma. Nonetheless and while most of the topics we 
identified were discussed in the previous two overviews 
[3, 4], our to date most extensive overview of system-
atic reviews on asthma epidemiology enables us to make 
some additions:
First, we identified 19 systematic reviews on the effects 
of smoking on asthma, principally covering environ-
mental tobacco smoke exposure which is discussed in 
the previous overview [3]. In addition, we identified 6 
systematic reviews on active smoking: one on asthma in 
women [24], one on gene-environment interaction with 
Glutathione-S-Transferase genes [17], one on marijuana 
smoking [25], one on the effects of smoke-free legisla-
tion [26], one evidence-based guideline on occupational 
asthma [27], and one on risk and protective factors [5]. 
The latter was published in 2004 and is the only one with 
a focus on the main effects of active smoking in a general 
population, suggesting an update is warranted.
Second, we identified several systematic reviews on 
the effects of specific infections other than RSV infec-
tion which is the only infection discussed in the previous 
overview [3]. A total of four systematic reviews on Heli-
cobacter pylori infection were included, one of poor qual-
ity [28]. The other three all conducted their search up to 
April to July 2012 [29–31]. However, one included only 
five studies and found no association [29]. The other two 
had 12 studies in common, including the aforementioned 
five studies and found weaker evidence for an inverse 
association between H. pylori infection and asthma [30, 
31]. This example documents how differing search and 
inclusion criteria may affect the overall interpretation of 
the assembled body of evidence. Our previous overview 
of systematic reviews in allergy epidemiology includes a 
discussion towards this issue [8].
Third, topics not covered by the previous overview 
include genetics (by methodology, n  =  76 systematic 
reviews), effects of physical activity or sedentary behav-
iour (n =  4), pet exposure (n =  6), and formula rather 
than breastfeeding (n =  8, including updates). Our pri-
mary purpose was not to discuss these systematic reviews 
in depth but to index them and provide quality scores 
for future reference. Still, our results indicate that spe-
cifically birth weight was covered by systematic reviews 
with low methodological quality. Here, the authors of the 
other overview [3] identified a further systematic review 
[32] published after our search period which achieved 
an AMSTAR score of 9 in their evaluation which poten-
tially closes this gap. Moreover, the second topic with 
only low quality systematic reviews published after 2010 
was “pets” which was not covered by the other overview 
and for which a high-quality update may be warranted. 
Table 1 Genes along  with the frequency they were cov-
ered by systematic reviews
a Including GSTT1 (n = 4), GSTM1 (n = 3), and GSTP1 (n = 2)
Gene(s) Number of systematic reviews
IL4 12
IL13 8
ADAM33, CCL5, TNF 7
ADRB2, CD14, IL4R 6
GSTa, IL10, TGFB1 4
ACE, CXCL8, IFNG, IL18, MS4A2, TLR4 3
CTLA4, FLG, LTA, LTC4S, STAT6 2
CFTR, HLA, IL1B, IL9, MBL2, NAT2, PTGDR, 
SCGB1A1, SERPINE1, SFTPD, TLR2
1
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In particular our conservative AMSTAR scores and our 
more comprehensive list may help to guide selection of 
further topics which may require new or updated system-
atic reviews. Whether an overview of systematic reviews 
for a specific topic or an update of an existing systematic 
review is warranted will also depend on scientific interest 
and closer investigation of the body of evidence covered 
by each individual systematic review.
Fourth, in our overview of systematic reviews on 
genetic factors implicated in asthma development, we 
were able to demonstrate that evidence from family-
based designs has largely been ignored, even though 
methodology to statistically combine this evidence with 
that from other study designs has been suggested and 
applied elsewhere [33]. Moreover, as we previously dis-
cussed [8], the nature of the search for articles covering 
genetics may make these more amenable to quick and 
efficient systematic review. Furthermore, the underly-
ing original articles have very homogenous definitions 
of the exposure variable (i.e. the genetic trait) and often 
report odds ratios which facilitates meta-analysis. For 
example, the effects of IL4 polymorphisms have been 
investigated in 12 systematic reviews published from 
2008 on with four of them in 2013 and three of them in 
2014. Four of these 12 reviews included only a single pol-
ymorphism within the gene. While there may be scien-
tific rationale to concentrate on specific polymorphisms 
(e.g. due to considerations of biology or those of linkage 
disequilibrium), it may be more appropriate to summa-
rize evidence at the gene level. Of note, our list of genes 
is not a comprehensive list of genetic factors implicated 
in asthma development but a reflection of which of these 
have been investigated by systematic reviews. There are 
many examples of large-scale meta-analyses on genetic 
factors (and also other factors as we discuss in our previ-
ous publication [8]) which we did not include and which 
may provide high-quality evidence.
Operational definitions of asthma have previously 
been shown to be heterogeneous [34, 35]. In system-
atic reviews on asthma, its definition in the underlying 
original articles needs to be extracted, displayed, and 
discussed. This was done in a substantial number of the 
systematic reviews included in our overview (data not 
shown). Additionally, atopic and non-atopic asthma were 
separated in some systematic reviews. Here, specific 
focus should be devoted to the definition of the compari-
son or reference groups in the original articles, as these 
definitions may dramatically influence resulting asso-
ciations [36]. We advocate that future systematic reviews 
continue to take a holistic approach with regard to speci-
fying asthma definitions as an inclusion criterion and 
that they evaluate and discuss potential heterogeneity of 
the asthma definitions used.
While the methodological quality of the systematic 
reviews has been generally increasing over the past dec-
ades, there were still up to 27% with low quality scores 
among those published after 2010. This may of course 
be a high estimate due to conservative application of the 
AMSTAR checklist and due to inclusion of a few articles 
in which the authors described a systematic search but 
did not aim at writing a systematic review. We have delib-
erately applied the AMSTAR checklist twice with more 
liberal and with more conservative instructions rather 
than averaging two replicate sets to produce a range of 
AMSTAR scores for each systematic review. The qual-
ity score from a consensus procedure would be likely 
to lie within this range. Indeed, for the 33 systematic 
reviews included in both our list and the only previous 
overview supplying AMSTAR scores [3], our conserva-
tive AMSTAR was consistently lower and our liberal 
AMSTAR was mostly equal or higher.
The AMSTAR checklist has been previously shown 
to yield higher scores for Cochrane reviews, if a meta-
analysis was conducted, and for more recently published 
systematic reviews [10, 37], all of which is reflected in 
our analyses. While these characteristics explained a 
larger portion of the overall variance in AMSTAR scores 
than our indexed aggregated topics, we could still detect 
some consistent differences across topics for both our 
AMSTAR definitions. The AMSTAR has also been shown 
to be associated with the number of pages of a system-
atic review [10] and the journal’s impact factor [37], but 
we refrained from evaluating these as we deemed them of 
lower importance to our aims. The AMSTAR interval we 
provide may guide future updates of existing systematic 
reviews in particular for those topics for which high qual-
ity systematic reviews are lacking as discussed above.
In conclusion, we present a comprehensive overview 
and an indexed database of published systematic reviews 
in asthma epidemiology including quality scores. We 
highlight some topics and issues which we believe should 
be considered in future systematic reviews. We propose 
that our results could be a basis for topic-specific over-
views of systematic reviews in asthma epidemiology.
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